Advertisement
YOU ARE HERE: LAT HomeCollectionsRoberts A Smith
IN THE NEWS

Roberts A Smith

FEATURED ARTICLES
BUSINESS
July 3, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
ICN Pharmaceuticals Inc., the company that Yugoslav immigrant Milan Panic built from scratch, is well-positioned to benefit financially from its founder's announcement Thursday that he will accept the post of prime minister for his troubled homeland, financial analysts said. But depending on who is talking, the reasons vary widely.
ARTICLES BY DATE
BUSINESS
July 3, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
ICN Pharmaceuticals Inc., the company that Yugoslav immigrant Milan Panic built from scratch, is well-positioned to benefit financially from its founder's announcement Thursday that he will accept the post of prime minister for his troubled homeland, financial analysts said. But depending on who is talking, the reasons vary widely.
Advertisement
BUSINESS
May 29, 1988
The article of May 22 entitled "Top 10 Executives' Average Pay Spirals Into Millions" gives the impression that ICN's drug ribavirin is of limited therapeutic value, when quite the opposite is true. Ribavirin is one of the most widely studied drugs in the world. It has been the subject of over 600 scientific papers in the peer review literature. It is approved in 28 countries for a variety of viral infections, including influenza, hepatitis and herpes simplex virus. It has been used therapeutically without reported fatalities by some 5 million patients throughout the world over the past decade.
BUSINESS
March 5, 1987 | ROBERT HANLEY, Times Staff Writer
ICN Pharmaceuticals Inc. was hit with two shareholder class-action lawsuits Wednesday that echo the accusations made in a similar suit filed last week that the Costa Mesa drug maker illegally inflated its stock price. The three lawsuits follow the opening of an equal number of federal inquiries into the company, including an investigation by the House Energy and Commerce Committee. In Wednesday's suits, two ICN shareholders accuse the company, its chairman, Milan Panic, director Roberts A.
BUSINESS
July 30, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
Adam Jerney, the Hungarian immigrant who by most accounts was long groomed to succeed Milan Panic as head of ICN Pharmaceuticals Inc.'s family of companies, has fulfilled his destiny--almost. The company announced on Wednesday that Jerney, 50, will take over Panic's role as chief executive officer of ICN Pharmaceuticals and two of its subsidiaries, SPI Pharmaceuticals Inc. and Viratek Inc. Fred Andrea, vice president of the third subsidiary--ICN Biomedicals Inc.
BUSINESS
July 11, 1996 | BARBARA MARSH, TIMES STAFF WRITER
Virazole has been the wonder drug for ICN Pharmaceuticals Inc., but shareholders simply wonder if it's ever going to be approved in the United States to combat any major illness. Over the years, ICN stock has risen and fallen on news that Virazole was being tested or wasn't being approved as a treatment for AIDS or the highly contagious hepatitis C liver ailment.
NEWS
July 15, 1992 | From Times Wire Services
A Costa Mesa businessman became Yugoslavia's prime minister Tuesday, promising to do his utmost to reach an immediate cease-fire in Bosnia-Herzegovina. Milan Panic said that lasting peace in Bosnia and stability in other Yugoslav regions are a necessity for solving the Yugoslav crisis. "My government will guarantee to the international community that it will do everything in order to turn this region into a factor of peace in Europe," he told Yugoslavia's Parliament.
MAGAZINE
June 21, 1987 | MARK CHRISTENSEN, Mark Christensen's novel "Mortal Belladaywick" will be published this month by Doubleday.
MILAN PANIC SAYS: "Aging begins when the DNA code fails to send a message to repair itself. If we can assist the DNA in sending a message to repair itself, the cells will not age. If the cells do not age, you do not age. We have solved the problem." Compact, well-dressed, handsome and fiftyish, Panic (pronounced Paa-nish) is nothing if not dynamic; his Eastern European accent and enthusiastic delivery make him sound equal parts Lee Iacocca and Boris Badenov.
BUSINESS
March 5, 1995 | JAMES S. GRANELLI, TIMES STAFF WRITER
Milan Panic was upset. He was reading stories last winter about an outbreak in Southern California of RSV, a respiratory ailment that afflicts children, and never saw a word about the only drug that treats serious RSV cases--the drug his company makes. A born salesman and autocratic leader, Panic ordered his staff at ICN Pharmaceuticals Inc. to put together a full-page advertisement for him to edit and approve.
Los Angeles Times Articles
|